GOALS OF WORK: Bone pain and functional impairment are major concerns for multiple myeloma (MM) patients. The goal of this study was to better define the role of percutaneous cementoplasty (PC) in improving their quality of life. MATERIALS AND METHODS: This retrospective analysis included 28 consecutive heavily pretreated MM patients managed at our institution between 1996 and 2002. They underwent a total of 34 PC procedures for the treatment of 117 vertebrae and 2 iliac sites and were evaluated at 1 month. MAIN RESULTS: Significant pain reduction of >50% was obtained after 83% of the procedures, with a mean visual analogous score decreasing from 7.48/10 to 2.1/10 (p < 0.001). It resulted in a complete interruption of opiate analgesic consumption after 59.3% of the procedures, with a mean decrease of 70.4% in the opiate dose. Functional impairment was evaluated with the Eastern Cooperative Oncology Group (ECOG) performance status scale, with mean scores improving from 1.9 to 0.86 after the procedures (p = 0.001). There was no major complication. CONCLUSION: PC is a safe, feasible, and efficient approach for the treatment of bone pain and disability in MM patients.
GOALS OF WORK: Bone pain and functional impairment are major concerns for multiple myeloma (MM) patients. The goal of this study was to better define the role of percutaneous cementoplasty (PC) in improving their quality of life. MATERIALS AND METHODS: This retrospective analysis included 28 consecutive heavily pretreated MMpatients managed at our institution between 1996 and 2002. They underwent a total of 34 PC procedures for the treatment of 117 vertebrae and 2 iliac sites and were evaluated at 1 month. MAIN RESULTS: Significant pain reduction of >50% was obtained after 83% of the procedures, with a mean visual analogous score decreasing from 7.48/10 to 2.1/10 (p < 0.001). It resulted in a complete interruption of opiate analgesic consumption after 59.3% of the procedures, with a mean decrease of 70.4% in the opiate dose. Functional impairment was evaluated with the Eastern Cooperative Oncology Group (ECOG) performance status scale, with mean scores improving from 1.9 to 0.86 after the procedures (p = 0.001). There was no major complication. CONCLUSION: PC is a safe, feasible, and efficient approach for the treatment of bone pain and disability in MMpatients.
Authors: Ann K Kim; Mary E Jensen; Jacques E Dion; Patricia A Schweickert; Timothy J Kaufmann; David F Kallmes Journal: Radiology Date: 2002-03 Impact factor: 11.105
Authors: J B Martin; B Jean; K Sugiu; D San Millán Ruíz; M Piotin; K Murphy; B Rüfenacht; M Muster; D A Rüfenacht Journal: Bone Date: 1999-08 Impact factor: 4.398
Authors: Alexis Kelekis; Karl O Lovblad; Amir Mehdizade; Thierry Somon; Hasan Yilmaz; Stefan G Wetzel; Yodith Seium; Pierre-Yves Dietrich; Daniel A Rufenacht; Jean-Baptiste Martin Journal: J Vasc Interv Radiol Date: 2005-01 Impact factor: 3.464
Authors: Daryl R Fourney; Donald F Schomer; Remi Nader; Jennifer Chlan-Fourney; Dima Suki; Kamran Ahrar; Laurence D Rhines; Ziya L Gokaslan Journal: J Neurosurg Date: 2003-01 Impact factor: 5.115
Authors: A Cotten; F Dewatre; B Cortet; R Assaker; D Leblond; B Duquesnoy; P Chastanet; J Clarisse Journal: Radiology Date: 1996-08 Impact factor: 11.105
Authors: Salvatore Masala; Tommaso Volpi; Francesco P M Fucci; Maria Cantonetti; Massimiliano Postorino; Giovanni Simonetti Journal: Support Care Cancer Date: 2010-05-27 Impact factor: 3.603
Authors: Manan Sunil Patel; Alexander Ghasem; Dylan N Greif; Samuel R Huntley; Sheila A Conway; Motasem Al Maaieh Journal: Int J Spine Surg Date: 2018-10-15